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Introduction
Biological aging is characterized by a progressive 
loss of organism’s functions from their physiological 
optimal values along the time as result of intrinsic 
and extrinsic factors (1; 2; 3). Several hypotheses 
may explain the causes of aging but only few are 
thoroughly accepted. One of them is related to the 
the loss of capacity of cell replacement in damaged 
tissues (4;5). 
Most of the tissues have a specific quantity of adult Stem 
Cells (SC) responsible for their periodic renovation 
and regeneration (6; 7). SC have the ability to self-
renew by symmetric divisions and the potentiality 
to differentiate into other cell types depending on 
their multipotency (9; 10).  The understanding of 
SC viability and regenerative capacity is one of the 
pillars of Regenerative Medicine (8). One type of 
adult SC are the mesenchymal SC derived from 
adipose tissue (ADSC), which have been used in our 
study. There are several procedures by which ADSC 
can be used to repair and regenerate tissues. For 
instance, ADSC transplantation into damaged tissues 
provokes a cytokine- and growth factor-induced 
response which stimulate their recovery ought to a 
SC microenviroment (niches) modulation caused 
by the ADSC presence. This could stimulate the 
differentiation of endogenous stem cells according to 
their lineage pathway. 
In this paper, the therapeutic potential of ADSC in 
Parkinson Disease (PD) has been studied in animal 
models by an intracranial injection of bacterial 
Lipopolysaccharide (LPS) in the substantia nigra (SN). 
This brain area, which is rich in dopaminergic neurons, 
is degenerated in PD. LPS-mediated dopaminergic 
neurotoxicity depends on the microglial activation, 
which releases pro-inflammatory factors (NO, 
TNF-α, IL-1β) (11; 12). Moreover, it was found 
that the neurotoxicity was mainly mediated by the 
activation of microglial NADPH-oxidase, generating 
ROS and neurotoxic factors (12). The aim of this 
study is to show how stem cells engraftments in an 
animal model of PD can produce a histological and 
functional improvement. 
Material and methods
Adipose stromal vascular fraction isolation
The stromal vascular fraction (SVF) was obtained from 
adipose tissue removed from lumbar or abdominal 
area of Wistar rat anesthetized with chloral hydrate 
6%. Adipose tissue was washed with phosphate buffer 
saline (PBS) to eliminate as much blood as possible.
The tissue was enzymatically processed by a 
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collagenase solution incubated at 37° C for 150 
minutes on an orbital shaker. Then, an equal volume 
of “stop medium” (Dulbecco’s Modified Eagle 
Medium-DMEM) with 10% fetal bovine serum (FBS) 
was added and samples were centrifuged at 600xg for 
10 min at 4ºC. The pellet (SVF) was resuspended in 
DMEM + FBS + antibiotic and the cell suspension 
was filtered through a 40 µm pore-size filter.
Magnetic separation of the ADSC using the 
CD90.1 MicroBeads.
In order to perform the extraction of the ADSC from 
a cellular suspension of SVF, a magnetic separation 
system based on MACS© technology (Magnetic 
Cell Sorting) were used. This procedure is based on 
the use of the so-called “microbeads” which are a 
magnetic micro-particles associated with antibodies 
that specifically recognize antigens on surface of 
stem cells. In our case, the CD90.1 (THYmocyte 
differentiation antigen-1.1) Microbeads antibody 
was chosen. After magnetic separation, cells were 
centrifuged, resuspended and cultivated with 
DMEM+FBS+antibiotic and finally incubated at 37 
° C. 
The Countess® Automated Cell Counter was used 
to determine the number of cells using the Trypan 
Blue assay. To verify if obtained cells are ADSC, the 
presence of CD90.1 and CD29 surface markers and 
the absence of CD11b, CD34, CD45 was checked by 
flow cytometry, using monoclonal antibodies labeled 
with fluorophores (mouse antiCD34-PE, CD45-PE, 
CD11b-PE, CD29-APC and CD90.1-FITC).
In vivo tracking of ADSC.
In vivo tracking systems using gene reporters is a useful 
tool for cell tracking before, during and after cells 
engraftment. Optical imaging technologies combined 
with the use of genetically encoded fluorescent and 
luminescent proteins have enabled the visualization 
of stem cells over in vivo and ex vivo periods of time.
ADSCs were infected with pSIN-DUA-Luciferasa-
GFP2 lentivirus with 8 µg/ml polybrene for 
24 h. The percentage of GFP-positive cells was 
determined by flow cytometry. Bioluminiscence 
activity was measured in vitro and in vivo using 
Xenogen IVIS Lumina II imaging system incubation 
with D-Luciferin (150 µg/ml). For the in vivo study, 
D-Luciferin was injected intraperitoneally at a dose 
of 150 mg/kg body weight.
Surgical procedure and injecion of LPS and 
stem cells.
Rats were anesthetized with chloral hydrate (400 
mg/kg) and positioned in a stereotaxic apparatus 
(Kopf Instruments, Tujunga, CA, USA) in accordance 
with the brain atlas of Paxinos and Watson (1986). 
Intracerebral surgery was performed by trepanation 
of the skull and injections into SN were made 5.4 
mm posterior, 1.8 mm lateral, and 8.3 mm ventral to 
bregma (Fig. 1.). Animals received 2 µl of vehicle (1% 
Monastral Blue) inert tracer in saline or 2 µl of LPS (8 
µg) (n = 4) or 2 µl of ADSC solution + LPS (3 x 105 
cells + 8 µg) in the SN. Experiments were carried out 
in accordance with the Guide-lines of the European 
Union Council following the Spanish regulations for 
the use of laboratory animals and approved by the 
Scientific Committee of the University of Seville. 
Figure 1. Intracerebral surgery
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Functional study of learning in operant 
conditioning chamber (Skinner box).
The experiment conducted in a Skinner box was as 
follows: the animal was starved for 24 hours. Later, 
once the rat pressed the lever, a mechanical device 
drops a pellet of food to the feeder installed inside the 
same box. After a period of time, the rat activates the 
lever and the food falls into the feeder. Rat eats pellets 
and returns to the lever. The process is repeated with 
insistence and rat runs incessantly from the feeder to 
the lever. The scheme of learning is the following:
S (conditioned Stimulus)à R (conditioned 
Response)à C (Consequence or Enhancer)
Goal-oriented learning
SàRàC
Habit learning
SàR
S: lever inside the box. R: pressure on the lever. 
C: pellet of food
The rats were trained with programs of fixed and 
variable series which result in a learning goal through 
enhancers. As a consequence of overtraining, the rats 
learnt a habit (i.e., some it is done unconsciously). 
On other hand, we could check if the animal kept 
pressing the lever even when the enhancer was 
devalued.
Immunohistochemical analysis
After perfusing the animal with intracardiac 
injection of paraformaldehyde, frontal lobes were 
removed. Thaw-mounted 20 µm coronal sections 
were cut with a cryostat at 20 ºC and mounted 
on gelatin-coated slides. The primary antibodies 
used were rabbit-derived anti-tyrosine hydroxylase 
(anti- TH, Sigma; 1:300) and mouse-derived OX-6 
(Serotec, Oxford, U.K.; 1:200). OX-6 is directed 
against a monomorphic determinant of the rat 
major histocompatibility complex (MHC) class II 
antigens, expressed by activated microglia but not 
by the resting cells. Incubations and washes for all 
the antibodies were in Tris-buffered saline (TBS), pH 
7.4. All work was performed at room temperature. 
Sections were washed and then treated with 0.3% 
hydrogen peroxide in methanol for 20 min, washed 
again, and incubated for 60 min in a humid chamber 
in a solution containing TBS and 1% horse serum 
(Vector Laboratories, Burlingame, CA, USA) for 
OX-6 immunostaining or goat serum (Vector) 
for TH immunostaining. Slides were drained and 
further incubated with the primary antibody in 
TBS containing 1% horse/goat serum and 0.25% 
Triton-X-100 for 24 h. Sections were then incubated 
for 2 h with biotinylated horse anti-mouse IgG 
(Vector, 1:200) for OX-6 immunostaining or 
biotinylated goat anti-rabbit IgG (Vector, 1:200) for 
TH immunostaining. The secondary antibodies was 
diluted in TBS containing 0.25% Triton-X-100, 
and prior to its addition three 10-min rinses in TBS 
were performed. Sections were then incubated with 
ExtrAvidin1-Peroxidase solution (Sigma, St Louis, 
MO, USA; 1:100). The peroxidase was visualized with 
a standard diaminobenzidine/hydrogen peroxide 
reaction for 5 min. 
For the measurement of the areas expressing OX-6 
and TH, the AnalySIS1 image software (Soft Imaging 
System GmbH, Mu¨ nster, Germany) coupled to a 
Polaroid DMC camera (Polaroid, Cambridge, MA, 
USA) attached to a Leika light microscope (Leika 
Mikroskopie, Wetzlar, Germany) was used. For each 
animal, five sections (sampling fraction 1:3) were 
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systematically sampled along the anterior-posterior 
axis from a random starting point, following 
stereological criteria. The number of TH-positive 
neurons in the SN was estimated using a fractionator 
sampling design. Counts were made at regular 
predetermined intervals (x = 150 µm and y = 200 
µm) within each section. An unbiased counting frame 
of known area (40 µm x 25 µm = 1000 µm2) was 
superimposed on the tissue section image under a 
100x oil immersion objective. Therefore, the area 
sampling fraction was 1000/(150 x 200) = 0.033. 
The entire z-dimension of each section was sampled; 
hence, the section thickness sampling fraction was 
1. In all animals, 20 µm sections, each 100 µm apart, 
were analyzed; thus, the fraction of sections sampled 
was 20/100 = 0.20. The number of neurons in 
the SN was estimated by multiplying the number 
of neurons counted by the reciprocals of the area 
sampling fraction and the fraction of section sampled.
Statistical analysis 
Results are expressed as mean ± SD. Means were 
compared by One-Way ANOVA followed by the 
LSD test for post hoc multiple range comparisons. An 
alpha level of 0.05 was used. The IBM SSPS Statistics 
21 package was used for the analyses.
Results
Transfection of ADSC with lentivirus
Transfected cells reached the confluence in 2 days. 
Then, the percentage of infected cells was determined 
by flow cytometry. 
On the density plot diagram (Fig. 2A), each dot or 
point represents an individual cell that has passed 
through the instrument. Cells have been gated 
as region 1 (R1). ‘Region’ simply refers to an area 
drawn on a plot displaying flow cytometry data. On 
the histogram plot (Fig. 2B) cells are now plotted as 
Counts on the y-axis versus GFP fluorescence on the 
x-axis.  The percentage of GFP+ cells were 69,2%. 
Figure 2. Density plot diagram (A) and Histogram plot of 
GFP expression (B). Measurement by flow cytometry in 
channel FL1.
“In vivo” tracking of the ADSC.
Bioluminiscence activity in vitro and vivo was 
determinated using Xenogen IVIS Lumina II 
imaging system and 3 x 105 cells in SN (5.5 mm 
posterior, 1.5 mm lateral, and 8.3 mm ventral). The 
injected cells emited 1.72 x 108 ± 5.83 x 107 p/s /
cm2/sr at 5 min of exposure time (Fig. 3). This result 
shows the possibility of in vivo tracking in central 
nervous system.
Figure 3. Photographs of optical bioluminescence 1 day after 
transplantation (1,721·108 p/s/cm²/sr).
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Effect of LPS on the microglial population.
In response to certain brain damage, either immune 
or inflammatory stimulus, microglia suffers significant 
morphological and metabolic changes. The activated 
microglia increases the expression of certain proteins, 
forming the so-called activated microglia (13, 14). 
Thus, this study aims to study the degree of activation 
of microglia in the SN in response to LPS injection 
by using the OX-6 antibody, which only marks the 
activated microglia.
Injection of vehicle into the SN induced only a 
slight OX-6 immunoreactivity around the injection 
track (Fig. 4). Besides, injecting LPS induced a 
clear microglial activation. LPS+ADSC injections 
prevented by 50 % this activation. 
Figure 4. Quantification of the area expressing OX-6 
immunoreactivity in the  SN. Results are mean ± SD. 
aStatistical signification compared with control and 
bstatistical signification compared with LPS group p< 0.01.
Effect of LPS on the number of TH positive 
neurons. 
The injection of vehicle did not affect the normal 
pattern of TH immunostaining in these structures 
(Fig. 5). The number of TH-positive neurons in 
the SN diminished significantly after the injection 
of LPS. However, in this case the decrease was 
partially limited thanks to the ADSC, because the 
results obtained have a higher standar deviation ( no 
entiendo muy bien en sentido de esta  frase). This 
result is consistent with previous results (15). 
Figure 5. Quantification of the area expressing TH 
immunoreactivity in the SN. Results are mean ± SD. 
aStatistical signification compared with control and 
bstatistical signification compared with LPS group p<0.05.
Functional study of learning.
Operant conditioning (also known as instrumental 
conditioning) is a process by which organisms learn 
to behave in such a way as to obtain rewards and avoid 
punishments. Habit learning is the process by which 
new behaviors become automatic. If an.acquired 
behavior is regularly followed, it becomes almost 
involuntary. 
To know if the injuries done in SN affect the 
dopaminergic activity by the neostriatum (striate 
dorsomedial and dorsolateral in rodents) we must 
take into account that the dorsomedial part is related 
to learning goal behaviours while the dorsolateral 
part is related to habits (16). Using the Skinner box, 
our results show that control animals acquired the 
skill in less time than both LPS- and LPS + ADSC-
treated animals (Fig. 6). 
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Figure 6.Learning acquisition time.
Figure 7. Decline of consumption of the devalued pellet.
To break the RàC connection in the operant 
conditioning and habit learning we used food pellet 
of LiCl that produce gastric discomfort to the animal 
so that they show an aversive behavior to eat it. Using 
these pellets we can assess whether the learning 
behavior was predominantly aimed at a goal or 
maintained by habit. As we can be seen in Fig. 7, LPS-
treated animals quickly lower their rate of response, 
which indicate that their learning is primarily aimed 
at a goal. It is worthy to note that LPS + ADSC 
animals showed a higher rate of response than control 
subjects, which suggests a greater ability to acquire a 
habit. 
Discussion
Cell therapy has been studied in a model of 
Parkinson’s disease (PD). The working hypothesis is 
that the ADSC, implanted locally, can recognize the 
damage and stay in these tissues during a period of 
time and, later, contribute to their reparation. The 
idea is that autologous treatments with ADSC would 
prevent or treat the loss of optimal neurophysiological 
functions occurring with age.
An LPS experimental model of PD was used. LPS 
induces a strong reaction in the microglia as indicated 
by a 67-fold increase in the OX-6 compared to 
control data. The SN has special sensitivity to 
the inflammation stimulus due to the fact that it 
contains the highest density of microglial cells (13). 
In addition, LPS led to a loss of more than 70% of 
TH positive neurons. It has been described that the 
increase in the synthesis of inflammatory cytokines 
by glia produces the selective death of dopaminergic 
neurons due to oxidative stress (18, 19, 20). 
Considering the inflammatory process that occurs 
in the SN after injection of LPS (15), it has been 
suggested that inflammation could be involved in 
certain neurodegenerative processes such as PD. 
The results also show that ADSC partially prevented 
both the microglial activation caused by LPS and the 
loss in the number of TH-positive neurons. Likewise, 
ADSC treatment led a slight tendency to observe a 
greater ability to acquire a habit. In conclusion, stem 
cells are capable of improving inflammation, neuronal 
death and possible improvements at the functional 
level in PD.
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